Scarica l'app Stockscreener
514.97
1.35%
-4.84
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ISRG Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$519.81
Aprire:
$520.89
Volume 24 ore:
442.33K
Relative Volume:
0.24
Capitalizzazione di mercato:
$182.21B
Reddito:
$8.35B
Utile/perdita netta:
$2.32B
Rapporto P/E:
80.34
EPS:
6.41
Flusso di cassa netto:
$1.30B
1 W Prestazione:
+4.21%
1M Prestazione:
-11.73%
6M Prestazione:
+5.44%
1 anno Prestazione:
+28.96%
Intervallo 1D:
$510.00
$520.89
Intervallo di 1 settimana:
$477.27
$520.89
Portata 52W:
$364.17
$616.00
Intuitive Surgical Inc Stock (ISRG) Company Profile
Nome
Intuitive Surgical Inc
Settore
Industria
Telefono
(408) 523-2100
Indirizzo
1020 KIFER ROAD, SUNNYVALE
Confronta ISRG con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ISRG
Intuitive Surgical Inc
|
515.36 | 182.21B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
229.66 | 66.11B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
91.45 | 45.01B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
224.02 | 32.73B | 4.93B | 1.25B | 1.38B | 8.47 |
|
WST
West Pharmaceutical Services Inc
|
225.08 | 16.82B | 2.88B | 499.60M | 321.60M | 6.74 |
Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-02 | Aggiornamento | Redburn Atlantic | Neutral → Buy |
| 2024-07-10 | Reiterato | Citigroup | Buy |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2023-11-17 | Iniziato | HSBC Securities | Buy |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-04-19 | Reiterato | BTIG Research | Buy |
| 2023-04-19 | Reiterato | BofA Securities | Buy |
| 2023-04-19 | Reiterato | Citigroup | Buy |
| 2023-04-19 | Reiterato | Evercore ISI | In-line |
| 2023-04-19 | Reiterato | JP Morgan | Overweight |
| 2023-04-19 | Reiterato | Morgan Stanley | Equal-Weight |
| 2023-04-19 | Reiterato | RBC Capital Mkts | Outperform |
| 2023-04-19 | Reiterato | Raymond James | Outperform |
| 2023-04-19 | Reiterato | Stifel | Buy |
| 2023-04-19 | Reiterato | Truist | Buy |
| 2023-04-19 | Reiterato | Wells Fargo | Overweight |
| 2023-03-29 | Iniziato | UBS | Neutral |
| 2023-03-23 | Iniziato | William Blair | Outperform |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-13 | Iniziato | Mizuho | Neutral |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-04-13 | Iniziato | Truist | Buy |
| 2022-04-06 | Iniziato | Wolfe Research | Peer Perform |
| 2022-03-25 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-02 | Aggiornamento | UBS | Neutral → Buy |
| 2022-01-31 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-01-25 | Downgrade | Redburn | Buy → Neutral |
| 2022-01-21 | Reiterato | BTIG Research | Buy |
| 2022-01-21 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-01-21 | Reiterato | Deutsche Bank | Hold |
| 2022-01-21 | Reiterato | Evercore ISI | In-line |
| 2022-01-21 | Reiterato | Morgan Stanley | Equal-Weight |
| 2022-01-21 | Reiterato | Piper Sandler | Neutral |
| 2022-01-21 | Reiterato | Raymond James | Outperform |
| 2022-01-21 | Reiterato | Robert W. Baird | Outperform |
| 2022-01-21 | Reiterato | Stifel | Buy |
| 2022-01-21 | Reiterato | UBS | Neutral |
| 2022-01-21 | Reiterato | Wells Fargo | Overweight |
| 2022-01-10 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2021-10-01 | Downgrade | Citigroup | Buy → Neutral |
| 2021-07-21 | Reiterato | BofA Securities | Neutral |
| 2021-07-21 | Reiterato | Citigroup | Buy |
| 2021-07-21 | Reiterato | JP Morgan | Overweight |
| 2021-07-21 | Reiterato | Morgan Stanley | Equal-Weight |
| 2021-07-21 | Reiterato | Piper Sandler | Neutral |
| 2021-07-21 | Reiterato | SVB Leerink | Mkt Perform |
| 2021-07-21 | Reiterato | Stifel | Buy |
| 2021-07-21 | Reiterato | UBS | Neutral |
| 2021-07-21 | Reiterato | Wells Fargo | Overweight |
| 2021-07-14 | Reiterato | Goldman | Buy |
| 2021-06-01 | Aggiornamento | Evercore ISI | Underperform → In-line |
| 2021-04-21 | Aggiornamento | Oppenheimer | Underperform → Perform |
| 2021-04-21 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2021-04-01 | Iniziato | Citigroup | Buy |
| 2020-12-15 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-09-28 | Iniziato | Argus | Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Outperform |
| 2020-09-08 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-09-02 | Iniziato | Robert W. Baird | Neutral |
| 2020-07-20 | Reiterato | Bernstein | Outperform |
| 2020-04-28 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-04-17 | Downgrade | CFRA | Hold → Sell |
| 2020-04-17 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-09 | Downgrade | Evercore ISI | In-line → Underperform |
| 2020-04-01 | Downgrade | Oppenheimer | Perform → Underperform |
| 2020-01-27 | Downgrade | Deutsche Bank | Buy → Hold |
| 2019-12-12 | Reiterato | Wells Fargo | Outperform |
| 2019-11-21 | Iniziato | Oppenheimer | Perform |
| 2019-07-19 | Reiterato | Canaccord Genuity | Buy |
| 2019-04-22 | Reiterato | Canaccord Genuity | Buy |
| 2019-04-02 | Iniziato | Deutsche Bank | Buy |
| 2018-10-31 | Reiterato | Piper Jaffray | Overweight |
| 2018-10-19 | Aggiornamento | Canaccord Genuity | Hold → Buy |
Mostra tutto
Intuitive Surgical Inc Borsa (ISRG) Ultime notizie
Automated Suturing Devices Market Size, Share, Comprehensive - openPR
Is Intuitive Surgical Inc. (ISRG) the High-Valuation Stock to Buy According to Billionaires? - Insider Monkey
Restore Robotics Wins FDA Nod to Remanufacture Da Vinci Xi Instruments - MPO-mag
Is Intuitive Surgical Stock a Buy? - The Motley Fool
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Unlocking Intrinsic Value: Analysis of Intuitive Surgical Inc - GuruFocus.com
Laparoscopic Devices Market 2025 Growth, Business - openPR
Intuitive Surgical Inc (ISRG) Stock Price Up 3.17% on Mar 24 - GuruFocus.com
Q4 Earnings Review: Surgical Equipment & ConsumablesSpecialty Stocks Led by Intuitive Surgical (NASDAQ:ISRG) - Yahoo Finance
Intuitive Surgical discloses pay for execs and median workers while urging votes against shareholder proposals - Medical Design & Outsourcing
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Benzinga
Intuitive Surgical is Known for Selling $1 Million Surgical Robots. But Here's How it Actually Makes Most of its Revenue. - MSN
Intuitive Surgical, Inc. (ISRG) Laps the Stock Market: Here's Why - MSN
Intuitive Surgical’s Biggest Moat Is NOT What You Think – Here’s Why It’s a Game-Changer! - Smartkarma
Medical Robotics Market is expected to reach US$ 61.33 billion - openPR
US Medical Robotics Market | Growth Trends, Innovations & - openPR
Intuitive Surgical, Inc. (ISRG) Stock Moves -0.99%: What You Should Know - MSN
This Is What Whales Are Betting On Intuitive Surgical - Benzinga
Is Intuitive Surgical (ISRG) a Buy as Wall Street Analysts Look Optimistic? - Yahoo Finance
Baird Adjusts Price Target on Intuitive Surgical to $600 From $707, Keeps Outperform Rating - Marketscreener.com
(ISRG) Technical Data - Stock Traders Daily
Intuitive Surgical, Inc. (ISRG): The Best Biotech Stock to Buy According to Billionaires - Yahoo Finance
Is Intuitive Surgical, Inc. (ISRG) a Best Biotech Stock According to Billionaires? - MSN
Robotic Rehabilitation And Assistive Technologies Market - openPR
Will ISRG Stock Drop Continue After da Vinci 5 Recall? - Yahoo Finance
Robotic Surgery Program Designated as Total Program Observation Site - Lehigh Valley Health Network
BofA Defending Intuitive Surgical (ISRG) - StreetInsider.com
Erste Group cuts Intuitive Surgical stock rating to Hold - Investing.com
Erste Group Downgrades Intuitive Surgical (ISRG) to Hold (Friday pre-market) - StreetInsider.com
Intuitive Surgical’s SWOT analysis: robotic surgery leader faces tariff headwinds - Investing.com India
Intuitive Surgical price target lowered to $605 from $666 at Truist - TipRanks
Intuitive Surgical stock target cut to $605 by Truist Securities - Investing.com India
Truist Adjusts Price Target on Intuitive Surgical to $605 From $666, Maintains Buy Rating - Marketscreener.com
Intuitive Surgical Positioned for Growth Amidst Rising Adoption of Robotic Surgeries - TipRanks
Global Robotic Surgical Procedures Market to Reach $32.54B by 2034: Trends & Forecast - openPR
Will Intuitive Surgical (ISRG) Beat Estimates Again in Its Next Earnings Report? - MSN
15 Best Biotech Stocks to Buy According to Billionaires - Insider Monkey
Intuitive Surgical stock soars to all-time high of $608 - MSN
SEC Form DEF 14A filed by Intuitive Surgical Inc. - Quantisnow
Intuitive Surgical exec sells shares for $5.76 million - Investing.com India
Validea Detailed Fundamental AnalysisISRG - Nasdaq
Intuitive Surgical’s Strong Market Position and Technological Advancements Justify Buy Rating - TipRanks
Intuitive Surgical Breaks Out After Robotic Surgery Giant Crushes Quarterly Forecasts - MSN
Intuitive Surgical Inc (ISRG) Stock Price Down 3.73% on Mar 13 - GuruFocus.com
ISRG Stock Price Falls to 200-DMA: Should You Buy, Hold or Sell? - Yahoo Finance
FDA says Intuitive da Vinci 5 foot pedal recall is Class II - Mass Device
Some medtech stocks hit by tariff turmoil more than others - Mass Device
ISRG May 2nd Options Begin Trading - Nasdaq
Intuitive Surgical: Leading The Next-Generation Surgery Market (NASDAQ:ISRG) - Seeking Alpha
3 Unparalleled Growth Stocks You'll Regret Not Buying During the Nasdaq Stock Correction - The Motley Fool
Intuitive surgical EVP sells shares worth $6.37 million - Investing.com
Intuitive Surgical Inc Azioni (ISRG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.47%
1.53%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):